Table 1.

Demographic features of the subjects recruited in the study

ID	Age	Sex	Race (Caucasian)	ALT/AST (U/l)	HCV genotype	Viral load (IU/ml)
P01	59	M	Yes	37/50	1a	4 790 000
P02	38	M	Yes	56/72	1a	38 200 000
P03	54	M	Yes	89/73	1a	1 890 000
P04	55	M	Yes	85/47	3a	50 000 000
P05	33	M	Yes	103/62	2b	40 100 000
P06	62	M	Yes	108/99	1a	97 965
P07	49	M	Yes	43/62	3a	11 641 000
P08	58	M	Yes	72/73	1b	530 590
P09	39	M	Yes	22/25	1a	992 000
P10	59	M	No	74/48	1a	2 110 000
P11	52	M	Yes	64/28	3a	10 000 000
P12	55	M	Yes	43/47	1a	3 640 000
P13	53	M	Yes	52/47	1a	2 180 000
P14	60	M	No	57/150	3a	26 800 000
P15	56	F	No	22/25	1b	5 780 000
P16	64	M	Yes	177/103	2b	50 000 000
P17	31	M	No	69/46	1b	23 000
P18	69	M	Yes	112/78	1a	2 210 000
P19	66	M	No	54/43	1a	1 100 000
P20	68	M	No	66/53	1a	790 000
P21	56	M	Yes	74/57	1a	1 360 233
P22	51	M	Yes	33/23	1b	13 321 000
P23	46	M	No	34/56	3a	2 560 000
P24	51	M	Yes	77/61	1a	188 897
P25	55	M	Yes	43/45	1b	1 132 878

Group summary	No. of subjects	Mean age (range), years	% of males	% of genotype 1	HCV-RNA (IU/ml)
HCV-infected patients	25	54 (31–69)	96	72	23 000–50 000 000
HCV-resolved individuals	15	51 (37–66)	100	NA	NA
Healthy subjects	14	44 (27–58)	85	NA	NA

ALT/AST, alanine aminotransferase/aspartate aminotransferase; NA, not applicable.